Title Image

R&D

Technology Platform
ONCORE™ Technology
Making Oncology Drugs Better

ONCORE™ is Handa’s proprietary drug delivery technology that was developed to improve the patient compliance and safety of the Tyrosine Kinase Inhibitor (TKI) class of oncology drugs.
ONCORE™ employs a unique salt / formulation that is capable of minimizing the pH effect of the drug in the gastrointestinal tract, which enables:

Elimination of the drug’s food effect.

Elimination of the acid reducing agent/Proton Pump Inhibitor (PPI) restrictions while taking the drug, which is prevalent with the TKI class.

ONCORE™ can also be used to improve a TKI’s systemic absorption, resulting in:

Dose reduction.

Reduced exposure of the drug in the gastrointestinal (GI) tract.

Increased safety profile to improve patient compliance.

judi online infini88 slot pg slot baccarat online slot idn live idn poker judi bola tangkasnet pragmatic slot88 sbobet slot deposit dana casino online vegas slot pokerseri joker123 autowin88 warungtoto selot